The two companies will share jointly in all proceeds on the placement of these specialized dispensing machines and specific consulting services provided by PVM. Cannabis Science will solely derive additional revenues by licensing formulations and products to existing and new PVM clinics. PVM generated $3.6 million in revenues over the last 4 quarters.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.